• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Encorium Acquisition Leads to CEO Move, COO Departure

Encorium Acquisition Leads to CEO Move, COO Departure

July 24, 2009
CenterWatch Staff

Wayne, Pa.-based contract research organization (CRO) Encorium Group has completed the sale of its U.S. business to Pierrel Research USA, a subsidiary of Italian CRO Pierrel SpA, for $2.7 million.

With the closing, Encorium announced that CEO David Ginsberg had joined Pierrel Research USA as its CEO, and chief operating officer Linda Nardone, Ph.D., has left the company. Pierrel has extended employment to most of Encorium’s U.S. employees and expects the CRO’s U.S. operations to continue largely unchanged.

Merge Healthcare also announced personnel changes as a result of its recently completed acquisition of etrials and the creation of a new division, Merge eClinical. The health IT solutions provider based in Milwaukee, Wisc., appointed Jon DeVries head of the new division. DeVries joins the company from Massachusetts General Hospital’s 3D visualization services. To align with the acquisition, Merge also announced an organization-wide staffing reduction, resulting in the elimination of 35 positions in North Carolina, Wisconsin and Ontario.

In other personnel news from the clinical trial industry:

Kendle appointed Jarrod Pontius to the position of chief legal officer, providing global leadership for all legal services, corporate governance and general corporate legal matters. Pontius was corporate counsel for Kendle from 2002 to 2007 before joining General Cable Corporation to serve as assistant general counsel.

Clinical Trials and Surveys Corp. (C-TASC) promoted Chris Donhauser to chief financial officer (CFO). Donhauser has served as executive director/treasurer to the CFO since 1999. As CFO, he will serve as the company’s top financial accountant responsible for managing C-TASC’s finances and leading client contract negotiations.

Upcoming Events

  • 25Apr

    Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials

  • 26Apr

    FDA’s New Laws and Regulations: What Drug and Biologics Manufacturers Need to Know

  • 27Apr

    Califf’s FDA, 2023 and Beyond: Key Developments, Insights and Analysis

  • 17May

    2023 WCG Avoca Quality Consortium Summit

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • tablet

    Digital Intake Platforms Effective as Source of Trial Information, Survey Shows

  • Diversity-360x240.png

    Site Spotlight: EmVenio Research Takes to the Road to Promote Trial Diversity

  • Five Ws

    Consider the Five ‘W’s to Understand Potential Participants

  • QandA-360x240.png

    Perspectives from Smaller-Sized CROs: Q&A with Cheryle Evans

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing